-
Sylatron OKed as add-on melanoma treatment
WHITEHOUSE STATION, N.J. — The Food and Drug Administration has approved a treatment made by Merck for treating skin cancer, Merck said Monday.
Merck announced the approval of Sylatron (peginterferon alfa-2b) as an add-on treatment for treating melanoma with microscopic of gross nodal involvement within 84 days of surgery.
-
Atkins boosts breakfast offerings
DENVER — Atkins Nutritionals is expanding its Day Break line with six new breakfast-inspired products.
New to the Atkins Day Break lineup are:
-
Breakfast shakes with resealable, twist-off caps in wild berry, creamy chocolate and strawberry banana flavors. Day Break shakes carry a suggested retail price of $6.99 for four shakes;
-
High-fiber soft-baked breakfast squares in blueberry almond and oatmeal cinnamon flavors, which cost $6.99 for five baked squares; and
-